# UCB Biosciences Inc. – FDA Inspection, Sep 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/ucb-biosciences-inc/aafd65d7-f9c0-4a00-a8c8-0754c6140762
Source feed: FDA_Inspections

> FDA inspection 1257452 of UCB Biosciences Inc., September 22, 2025. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257452
- Company Name: UCB Biosciences Inc.
- Inspection Date: 2025-09-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1330750 - 2026-07-29
- FDA Inspection 922071 - 2015-03-19
- FDA Inspection 675436 - 2010-08-03
- FDA Inspection 577683 - 2009-04-09

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-r-coleman/6fc13ec4-a609-4c3c-961f-16cba13a3a3a)

Company: https://www.keypedia.com/companies/ucb-biosciences-inc/88724ce5-8d46-4051-86eb-c5c07cee58eb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c